(Q45355050)

13 December 2017

Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool (English)

1 reference

13 December 2017

0 references

2

1 reference

13 December 2017

4

Josef Mautner

1 reference

13 December 2017

Benjamin M Fiebiger

1

1 reference

PubMed ID

22944914

13 December 2017

Uta Behrends

series ordinal

3

1 reference

PubMed ID

22944914

13 December 2017

language of work or name

English

0 references

publication date

16 October 2012

1 reference

European Journal of Immunology

13 December 2017

1 reference

13 December 2017

42

1 reference

13 December 2017

3167-3173

1 reference

13 December 2017

12

1 reference

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

13 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

DRiPs solidify: progress in understanding endogenous MHC class I antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

The synthesis of truncated polypeptides for immune surveillance and viral evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

The role of mRNA translation in direct MHC class I antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Global protein stability profiling in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Viral alteration of cellular translational machinery increases defective ribosomal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Post-translational modifications of naturally processed MHC-binding epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Stringent doxycycline-dependent control of gene activities using an episomal one-vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

The major substrates for TAP in vivo are derived from newly synthesized proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

inferred from DOI database lookup

7 January 2021

based on heuristic

When mutants gain new powers: news from the mutant p53 field.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242627

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.201242627

1 reference

13 December 2017

1 reference

PubMed ID

22944914